Novartis AG – Strategy, SWOT and Corporate Finance Report
- Pages: 88
- Published: February 2019
- Report Code: MLPH24864FSA
Novartis AG – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.
Novartis AG (Novartis) is a healthcare company that focuses on the discovery, development, manufacture and marketing of prescription and generic pharmaceutical products and eye care products. It provides drugs for the treatment of cancer, cardiovascular diseases, dermatological conditions, neurological disorders, ophthalmic and respiratory diseases, immune disorders, and infections among others. The company offers eye care products through its subsidiary, Alcon; and generic medicines and biosimilars through Sandoz. Novartis conducts research in various disease areas through The Novartis Institutes for BioMedical Research (NIBR). The company operates through a network of subsidiaries and offices in the Americas, Europe, the Middle East, Africa and Asia-Pacific. Novartis is headquartered in Basel, Switzerland.
Scope
Detailed information on Novartis AG required for business and competitor intelligence needs
A study of the major internal and external factors affecting Novartis AG in the form of a SWOT analysis
An in-depth view of the business model of Novartis AG including a breakdown and examination of key business segments
News about Novartis AG, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
Gain understanding of Novartis AG and the factors that influence its strategies.Track strategic initiatives of the company and latest corporate news and actions.
Assess Novartis AG as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on Novartis AGs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
SwitchGear Genomics Inc
Sanofi
Pfizer Inc
Novo Nordisk AS
Merck & Co Inc
Johnson & Johnson
GlaxoSmithKline Plc
Flarer SA
F. Hoffmann-La Roche Ltd
Eli Lilly and Co
Bristol-Myers Squibb Co
AstraZeneca Plc
Amgen Inc
AbbVie Inc
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.